Marshall Wace Asia’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$509K Sell
4,830
-14,971
-76% -$2.15M 0.01% 107
2021
Q2
$3.5M Buy
+19,801
New +$3.19M 0.07% 91

Other funds holding ZLAB

Marshall Wace Asia's ZLAB Position: Q3 2021 in Review

Marshall Wace Asia reduced its Zai Lab (ZLAB) stake by 76% in Q3 2021, selling an estimated $2.15M and leaving 4,830 shares worth $509K. The position accounts for 0.01% of the portfolio, ranked #107.

Marshall Wace Asia first reported a position in ZLAB in Q2 2021 and has held it in 2 quarters since. The position peaked at $3.5M in Q2 2021. 227 funds tracked by Wall St. Rank hold ZLAB as of Q3 2021.

  • Marshall Wace Asia held 4,830 shares of Zai Lab worth $509K as of Q3 2021.
  • Marshall Wace Asia sold 14,971 Zai Lab shares in Q3 2021, an estimated $2.15M.
  • Zai Lab made up 0.01% of Marshall Wace Asia's portfolio in Q3 2021, its #107 holding.
  • Marshall Wace Asia first reported a position in Zai Lab in Q2 2021 and has held it in 2 quarters since.
  • Marshall Wace Asia's Zai Lab position peaked at $3.5M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held Zai Lab as of Q3 2021.

Based on Marshall Wace Asia's 13F filing for Q3 2021, filed 15 Nov 2021.